NO20090395L - Farmasoytiske preparater inneholdende monoklonale antidiotype anti-CA-125-antistoff og aluminiumderivater - Google Patents

Farmasoytiske preparater inneholdende monoklonale antidiotype anti-CA-125-antistoff og aluminiumderivater

Info

Publication number
NO20090395L
NO20090395L NO20090395A NO20090395A NO20090395L NO 20090395 L NO20090395 L NO 20090395L NO 20090395 A NO20090395 A NO 20090395A NO 20090395 A NO20090395 A NO 20090395A NO 20090395 L NO20090395 L NO 20090395L
Authority
NO
Norway
Prior art keywords
antibody
pharmaceutical preparations
preparations containing
containing anti
monoclonal antibody
Prior art date
Application number
NO20090395A
Other languages
English (en)
Norwegian (no)
Inventor
Jens Flemming
Karsten Groger
Reinhard Schmitz
Stefano Manzini
Original Assignee
Menarini Int Operations Lu Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Int Operations Lu Sa filed Critical Menarini Int Operations Lu Sa
Publication of NO20090395L publication Critical patent/NO20090395L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39566—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against immunoglobulins, e.g. anti-idiotypic antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO20090395A 2006-06-29 2009-01-27 Farmasoytiske preparater inneholdende monoklonale antidiotype anti-CA-125-antistoff og aluminiumderivater NO20090395L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000163A ITFI20060163A1 (it) 2006-06-29 2006-06-29 Composizione farmaceutica contenente un anticorpo monoclonale anti idiotipico anti-ca-125 ed alluminio
PCT/EP2007/056465 WO2008000789A2 (en) 2006-06-29 2007-06-28 Pharmaceutical compositions containing monoclonal anti idiotypic anti-ca-125 antibody and aluminium derivatives

Publications (1)

Publication Number Publication Date
NO20090395L true NO20090395L (no) 2009-01-27

Family

ID=37439367

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090395A NO20090395L (no) 2006-06-29 2009-01-27 Farmasoytiske preparater inneholdende monoklonale antidiotype anti-CA-125-antistoff og aluminiumderivater

Country Status (35)

Country Link
US (2) US20100040625A1 (pt)
EP (2) EP2040749B1 (pt)
JP (1) JP2009541448A (pt)
KR (1) KR20090024240A (pt)
CN (1) CN101478987A (pt)
AP (1) AP2009004741A0 (pt)
AR (1) AR061364A1 (pt)
AT (1) ATE502649T1 (pt)
AU (1) AU2007263690A1 (pt)
BR (1) BRPI0713343A2 (pt)
CA (1) CA2655733A1 (pt)
CL (1) CL2007001888A1 (pt)
CR (1) CR10589A (pt)
CY (1) CY1111527T1 (pt)
DE (1) DE602007013402D1 (pt)
DK (1) DK2040749T3 (pt)
EA (1) EA015543B1 (pt)
EC (1) ECSP099089A (pt)
ES (1) ES2363616T3 (pt)
HK (1) HK1126417A1 (pt)
HR (1) HRP20110413T1 (pt)
IL (1) IL196148A0 (pt)
IT (1) ITFI20060163A1 (pt)
MA (1) MA30691B1 (pt)
MX (1) MX2008016059A (pt)
NO (1) NO20090395L (pt)
PE (1) PE20080269A1 (pt)
PL (1) PL2040749T3 (pt)
PT (1) PT2040749E (pt)
RS (1) RS51683B (pt)
SI (1) SI2040749T1 (pt)
TN (1) TNSN08485A1 (pt)
UA (1) UA95806C2 (pt)
WO (1) WO2008000789A2 (pt)
ZA (1) ZA200900563B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160279239A1 (en) 2011-05-02 2016-09-29 Immunomedics, Inc. Subcutaneous administration of anti-cd74 antibody for systemic lupus erythematosus and autoimmune disease
US20160355591A1 (en) 2011-05-02 2016-12-08 Immunomedics, Inc. Subcutaneous anti-hla-dr monoclonal antibody for treatment of hematologic malignancies
ITFI20060163A1 (it) * 2006-06-29 2006-09-28 Menarini Internat Operations Luxembourg Sa Composizione farmaceutica contenente un anticorpo monoclonale anti idiotipico anti-ca-125 ed alluminio
AU2012250924B2 (en) 2011-05-02 2017-05-25 Immunomedics, Inc. Ultrafiltration concentration of allotype selected antibodies for small-volume administration
CN110352201A (zh) 2017-04-03 2019-10-18 免疫医疗公司 用于癌症疗法的抗体药物缀合物的皮下施用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5127731B1 (pt) * 1971-05-12 1976-08-14
FR2565825B1 (fr) * 1984-06-15 1990-07-13 Centre Nat Rech Scient Vaccin contre les maladies dues a des microorganismes tels que des mycoplasmes, sa preparation et membranes de microorganismes en tant que principe actif
CA2163868C (en) 1993-05-27 2008-01-08 Uwe Wagner Monoclonal anti-idiotypic anti-ca125 antibodies and pharmaceutical compositions containing them
US5690942A (en) * 1995-06-02 1997-11-25 American Home Products Corporation Adjuvants for viral vaccines
US5718904A (en) * 1995-06-02 1998-02-17 American Home Products Corporation Adjuvants for viral vaccines
GB9808485D0 (en) * 1998-04-21 1998-06-17 Univ Cambridge Tech Improvements relating to immunotherapy
US6586403B1 (en) * 2000-07-20 2003-07-01 Salpep Biotechnology, Inc. Treating allergic reactions and inflammatory responses with tri-and dipeptides
US6585981B1 (en) * 2000-07-27 2003-07-01 Regents Of The University Of Minnesota Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae
CU23007A1 (es) * 2001-04-06 2004-12-17 Ct De Inmunologia Molecular Ct De Inmunologia Mole Combinaciones inmunoterapéuticas para el tratamiencombinaciones inmunoterapéuticas para el tratamiento de tumores que sobre-expresan gangliósidos to de tumores que sobre-expresan gangliósidos
US7537767B2 (en) * 2003-03-26 2009-05-26 Cytis Biotechnology Ag Melan-A- carrier conjugates
ITFI20060163A1 (it) * 2006-06-29 2006-09-28 Menarini Internat Operations Luxembourg Sa Composizione farmaceutica contenente un anticorpo monoclonale anti idiotipico anti-ca-125 ed alluminio

Also Published As

Publication number Publication date
ECSP099089A (es) 2009-02-27
KR20090024240A (ko) 2009-03-06
US20090104184A1 (en) 2009-04-23
BRPI0713343A2 (pt) 2012-03-13
AR061364A1 (es) 2008-08-20
RS51683B (en) 2011-10-31
ITFI20060163A1 (it) 2006-09-28
EP2228073A1 (en) 2010-09-15
CR10589A (es) 2009-03-30
TNSN08485A1 (en) 2010-04-14
HK1126417A1 (en) 2009-09-04
EA200900085A1 (ru) 2009-06-30
PT2040749E (pt) 2011-06-30
EP2040749A2 (en) 2009-04-01
WO2008000789A2 (en) 2008-01-03
ES2363616T3 (es) 2011-08-10
EA015543B1 (ru) 2011-08-30
CL2007001888A1 (es) 2008-04-18
MX2008016059A (es) 2009-01-15
ZA200900563B (en) 2010-03-31
DK2040749T3 (da) 2011-06-14
EP2040749B1 (en) 2011-03-23
SI2040749T1 (sl) 2011-06-30
ATE502649T1 (de) 2011-04-15
DE602007013402D1 (de) 2011-05-05
PL2040749T3 (pl) 2011-09-30
IL196148A0 (en) 2011-08-01
HRP20110413T1 (hr) 2011-07-31
AP2009004741A0 (en) 2009-02-28
CN101478987A (zh) 2009-07-08
JP2009541448A (ja) 2009-11-26
UA95806C2 (ru) 2011-09-12
PE20080269A1 (es) 2008-05-09
AU2007263690A1 (en) 2008-01-03
CY1111527T1 (el) 2015-08-05
MA30691B1 (fr) 2009-09-01
CA2655733A1 (en) 2008-01-03
WO2008000789A3 (en) 2008-02-28
US20100040625A1 (en) 2010-02-18

Similar Documents

Publication Publication Date Title
NO20083895L (no) Anti-IGF-1R human monoklonalantibody formulering
AR106944A2 (es) Compuestos de isoindolina y composiciones farmacéuticas de los mismos
NO20170633A1 (no) Forbindelser av indolamin-2,3-dioksygenase for anvendelse i behandling av kreft i kombinasjon med et anti-PD-1 antistoff .
EA200870545A1 (ru) Новые гетероциклические соединения
BRPI0520669A2 (pt) dosagem farmacêutica que reduz o efeito do alimento encontrado para administração de atorvastatina
CY1114892T1 (el) Φαρμακευτικη συνθεση ενος ισχυρου αναστολεα του hcv για απο του στοματος χορηγηση
EA200802170A1 (ru) Лиофилизированная композиция терапевтического пептидного антитела
NO20090628L (no) Pyridizinon derivativater
CL2010001426A1 (es) Compuestos derivados de triciclos, inhibidores de la proteina quinasa; composicion farmaceutica que los comprende; utiles en el tratamiento de enfermedades oncologicas e inmunologicas.
NO20084752L (no) Konjugater av aziridinayl-epotilonanaloger og farmasoytiske sammensetninger som inneholder disse
DK3421471T3 (da) Purin- og deazapurinderivater som farmaceutiske forbindelser
NO20080246L (no) Anti-IGF1R-antistofformuleringer
AR058433A1 (es) Derivado de 1,1-dioxido de 1,4-benzotiazepina ,procedimiento para su preparacion ,medicamentos que comprenden este compuesto y su uso
BRPI0518904A2 (pt) formulaÇÕes de nepafenac tàpicas
ECSP088296A (es) Compuestos terapéuticos
CL2008002295A1 (es) Compuestos derivados de tiazolida sustituidos con alquilsulfonilos; composicion farmaceutica; y uso para el tratamiento de la hepatitis c.
CL2008001258A1 (es) Kit de vacuna que comprende al menos nueve conjugados de sacaridos de antgenos hb o hib, donde al menos 2-7 son con la proteina transportadora crm, siendo dicho kit adecuado para usar en su calendario de inmunizacion primaria; vacuna combinada adecuada para la inmunizacion primaria.
BRPI0606506A2 (pt) polipeptìdeos de yersinia spp. e métodos de uso
BRPI0714885B8 (pt) compostos terapêuticos e seu uso
NO20090395L (no) Farmasoytiske preparater inneholdende monoklonale antidiotype anti-CA-125-antistoff og aluminiumderivater
BRPI0713031B8 (pt) composto de di-hidro-piran-2-ona, composição farmacêutica, e uso dos mesmos
NO20074933L (no) Farmasoytisk sammensetning som innbefatter et indolylmaleimidderivat
DE502007005902D1 (de) -methyl-19-nor-20- spirox-4-en-3-one), sowie diese enthaltende pharmazeutische präparate
EA200870148A1 (ru) Производные сулиндака, их применение и получение
ECSP045493A (es) Nuevas composiciones farmacéuticas que contienen flibanserina polimorfo a

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application